Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

9.02
BATS BZX Real-Time Price
As of 11:05am ET
 +0.10 / +1.12%
Today’s Change
7.12
Today|||52-Week Range
11.63
+5.25%
Year-to-Date

Today’s Trading

Previous close8.92
Today’s open8.79
Day’s range8.79 - 9.05
Volume2,484
Average volume (3 months)376,406
Market cap$717.3M
Dividend yield--
Data as of 11:05am ET, 11/21/2017

Growth & Valuation

Earnings growth (last year)-875.00%
Earnings growth (this year)-17.04%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+144.57%
P/E ratioNM
Price/Sales2.72
Price/Book4.28

Competitors

 Today’s
change
Today’s
% change
NTRANatera Inc+0.38+3.98%
ENZEnzo Biochem Inc+0.11+1.18%
KANGiKang Healthcare Gro...+0.08+0.55%
RDNTRadNet Inc+0.30+3.05%
Data as of 11:05am ET, 11/21/2017

Financials

Next reporting dateFebruary 15, 2018
EPS forecast (this quarter)$0.04
Annual revenue (last year)$244.1M
Annual profit (last year)-$5.7M
Net profit margin-2.34%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. Van Oort
Chief Scientific Officer &
VP-Operations
Steven G. Brodie
Corporate headquarters
Fort Myers, Florida

Forecasts